# Hormone Replacement Trial Against ALzheimers' Disease

> **NCT04312399** · NA · RECRUITING · sponsor: **University Hospital, Ghent** · enrollment: 600 (estimated)

## Conditions studied

- Postmenopausal Symptoms
- Alzheimer Disease

## Interventions

- **PROCEDURE:** blood take

## Key facts

- **NCT ID:** NCT04312399
- **Lead sponsor:** University Hospital, Ghent
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-04-17
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2025-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04312399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04312399, "Hormone Replacement Trial Against ALzheimers' Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04312399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*